BioSpace News Archive

KaliVir Immunotherapeutics, Inc. has unveiled its state-of-the-art GMP cleanroom facility to manufacture its pipeline of oncolytic viruses.

OKYO Pharma Limited announces that following its positive safety and efficacy results in its Phase 2 trial of OK-101, distinguished ophthalmologists, Victor Perez, M.D. and Anat Galor, M.D., both from the Bascom Palmer Eye Institute, and Mark Milner, M.D., of the Goldman Eye in Palm Beach Gardens, Florida, have joined OKYO’s Scientific Advisory board.

Tevogen Bio Inc is looking forward to and continues to work toward the anticipated closing of its proposed business combination with Semper Paratus Acquisition Corporation.

Conduit Pharmaceuticals Inc. today announced CEO Dr. David Tapolczay, will be participating in the Oppenheimer 34th Annual Healthcare Life Sciences Conference, being held February 13-14, 2024.

Kane Biotech Inc. announces that it has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel, and will be introducing it today at the Boswick Burn and Wound Care Symposium.

Neuronoff, Inc. today announced the successful completion of the first-in-human implant of the Injectrode®.

Global health company The Cigna Group (NYSE:CI) will be hosting its Investor Day on Thursday, March 7, 2024 in New York City.

Plasmonics are special optical phenomena that are understood as interactions between light and matter and possess diverse shapes, material compositions, and symmetry-related behavior.

Inherent Biosciences, Inc. and Genomic Prediction, Inc. (North Brunswick, NJ) are thrilled to announce a comprehensive commercial partnership agreement.

Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that management will participate in the following upcoming investor conferences.